Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2005
03/09/2005EP1511726A1 Method for preparing 1,3,5-triaminobenzene and hydrolyzing it into high-purity phloroglucinol
03/09/2005EP1511725A1 24-SULFOXIMINE VITAMIN D sb 3 /sb COMPOUNDS
03/09/2005EP1511723A1 Sulfone liver x-receptor modulators
03/09/2005EP1511722A1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof
03/09/2005EP1511721A2 Guanidino phenylalanin compounds used as urokinase inhibitors
03/09/2005EP1511719A1 Amide derivatives as inhibitors of the enzymatic activity of renin
03/09/2005EP1511718A1 N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors
03/09/2005EP1511717A1 Crystalline form of nateglinide
03/09/2005EP1511716A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
03/09/2005EP1511713A2 Compounds that abrogate dna-damage-induced cell cycle g2 checkpoint and/or augment the anti-cancer activity of dna-damaging treatments
03/09/2005EP1511710A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer s disease, type 2 diabetes, and parkinson s disease
03/09/2005EP1511706A1 Preparations containing conjugated linoleic alcohol
03/09/2005EP1511517A1 Formulation for parenteral administration of sodium channel blockers
03/09/2005EP1511516A1 Topically applicable pharmaceutical preparation
03/09/2005EP1511514A1 Fp receptor antagonists or pgf2 alpha antagonists for treating pathological conditions of the uterus
03/09/2005EP1511509A1 Compositions and methods for treating diabetes
03/09/2005EP1511508A2 Method of treating dyslipidemic disorders
03/09/2005EP1511506A1 Compositions and methods for preventing, treating and diagnosing diabetes
03/09/2005EP1511505A2 Novel therapies and methods of screening for therapeutic compounds
03/09/2005EP1511504A1 Anti-helicobacter activity of celery seed extract
03/09/2005EP1511500A2 Combination of anti-muscarinic agents and non-glucocorticoid steroids
03/09/2005EP1511499A2 Immunomodulatory compounds and methods of use thereof
03/09/2005EP1511498A1 A method of treating human skin and a skin care composition for use in such a method
03/09/2005EP1511497A1 Treatment of post-menopausal complaints in breast cancer patients which comprises tibolone and a serm
03/09/2005EP1511496A1 Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein
03/09/2005EP1511495A1 Progestagenic dosage units
03/09/2005EP1511494A1 Androgen pharmaceutical composition and method for treating depression
03/09/2005EP1511493A1 Use of peroxovanadium compounds as tumour cell growth suppressor
03/09/2005EP1511490A2 Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods
03/09/2005EP1511489A1 New pharmaceutical compositions containing flibanserin polymorph a
03/09/2005EP1511488A2 Human adam-10 inhibitors
03/09/2005EP1511487A1 Novel formulation for the parenteral application of crobenetine
03/09/2005EP1511486A1 Use of dopamine partial agonists for the treatment of the restless legs syndrome and corresponding pharmaceutical preparation
03/09/2005EP1511485A1 Novel uses of dl-thp
03/09/2005EP1511484A1 Combination of a dpp iv inhibitor and a cardiovascular compound
03/09/2005EP1511483A2 Methods of treatment with lxr modulators
03/09/2005EP1511482A1 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
03/09/2005EP1511481A1 Ophthalmological use of roflumilast for the treatment of diseases of the eye
03/09/2005EP1511480A2 Inhibitors of glycoprotein vi
03/09/2005EP1511479A1 Treatment of neuropathic pain
03/09/2005EP1511478A2 Triptolide derivatives for modulation of apoptosis and immunosuppression
03/09/2005EP1511477A1 Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
03/09/2005EP1511476A2 Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same
03/09/2005EP1511475A1 A herbal molecule as potential anti-leukemic drug
03/09/2005EP1511474A1 A method of treatment
03/09/2005EP1511473A2 Bis-aromatic alkanols
03/09/2005EP1511472A2 Compounds useful in the treatment of anthrax and inhibiting lethal factor
03/09/2005EP1511468A1 Nanoparticulate sterol formulations and sterol combinations
03/09/2005EP1511467A1 Nanoparticulate polycosanol formulations and novel polycosanol combinations
03/09/2005EP1511466A1 Use of glycosaminoglycans such as e.g. heparin for the treatment of respiratory disorders such as copd
03/09/2005EP1511462A1 Compositions containing dolichol for dermatological and cosmetic use
03/09/2005EP1511397A1 Dietary method for modulatng glucose metabolism and associated conditions and increasing longevity
03/09/2005EP1511393A1 A method of improving the growth performance of an animal
03/09/2005EP1511385A1 Insecticidal amides with nitrogen-containing benzo-fused bicyclic ring systems
03/09/2005EP1511381A1 Disinfectant with activity against hepatitis b virus
03/09/2005EP1511379A1 Prevention or treatment of abnormal lipoprotein, cholestasis and atherosclerosis
03/09/2005EP1480985B1 Salt of benzosulfonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations
03/09/2005EP1451188B1 4-(oxadiazol-3-yl)-1,4-diazabicyclo 3.2.2]-nonane derivatives, preparation and therapeutic use thereof
03/09/2005EP1429798A4 Optimal compositions and methods thereof for treating hcv infections
03/09/2005EP1401397B1 Pharmaceutical formulation having a masked taste and method for the production thereof
03/09/2005EP1370549A4 Methods for the preparation of mirtazapine intermediates
03/09/2005EP1345892B1 Acylaminoalkyl-substituted benzenesulfonamide derivatives
03/09/2005EP1307440B1 2,2-disubstituted 1,3-dioxolanes as antitussive agents
03/09/2005EP1303261B1 Self-emulsifying drug delivery systems for extremely water-insoluble, lipophilic drugs
03/09/2005EP1289512B1 Agents and methods for increasing brain chaperonin levels
03/09/2005EP1272499B1 Pharmaceutical compositions containing oligosaccharides and preparation thereof
03/09/2005EP1255552B1 Prostaglandin compositions for the treatment for male erectile dysfunction
03/09/2005EP1237916B1 Ing2, an iaps associated cell cycle protein, compositions and methods of use
03/09/2005EP1202969B1 Biphenyl derivatives, production thereof and use as medicines
03/09/2005EP1162959B1 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation
03/09/2005EP1143950B1 Topical application products against onychomycoses
03/09/2005EP1140112B1 Etherlysophospholipids for the treatment of chronic inflammatory diseases
03/09/2005EP1137429B1 Cherry extracts for inhibiting cyclooxygenase enzymes
03/09/2005EP1126849B1 Heterocyclic potassium channel inhibitors
03/09/2005EP1124536B1 Propofol composition comprising pentetate
03/09/2005EP1108026B1 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same
03/09/2005EP1085884B1 Combination of compounds containing selenium and gemcitabine or mitomycin c
03/09/2005EP1080723B1 INHIBITION OF IgA PRODUCTION
03/09/2005EP1057814B1 Tetrahydrobenzindole derivatives
03/09/2005EP1054680B1 Treatment of bladder cancer by mycobacterium phlei cell wall
03/09/2005EP1054670B1 Use of chelating agents in the treatment of atherosclerotic conditions
03/09/2005EP1018008B1 Method of identification of leads or active compounds
03/09/2005EP1003501B1 Use of an agent for lowering the risk of cardiovascular disease
03/09/2005EP0998276B1 Use of alkanoyl carnitine derivatives for the treatment of attention-deficit/hyperactive disorders
03/09/2005EP0991408B1 Novel process for manufacturing paroxetine solid dispersions
03/09/2005EP0973504B1 Hemostatic aerosol composition
03/09/2005EP0932613B1 Blocking expression of virulence factors in s. aureus
03/09/2005EP0876612B1 Method for identifying sex specific and species specific molecules, molecules identified using the method, and uses of the molecules
03/09/2005EP0848592B2 Antistress agents for aquatic animals
03/09/2005EP0842273B1 Receptor ligand vegf-c
03/09/2005EP0839149B9 Galanthamine derivatives, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing such derivatives
03/09/2005EP0831847B1 Method of synthesis of di-beta-d-glucopyranosylamine compounds for controlling inflammatory reactions
03/09/2005EP0817627B1 Protein kinase c inhibitors
03/09/2005EP0756005B1 Gene coding for adseverin
03/09/2005EP0673241B1 Use of a free radical quenching liposomal composition for the manufacture of a medicament for the treatment of inflammatory conditions
03/09/2005CN1592794A Cell culture system for synthesis of infectious hepatitis C virus
03/09/2005CN1592793A Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas
03/09/2005CN1592755A Anti-angiogenic peptides
03/09/2005CN1592748A Separation of regioisomers of metal phthalocyanines
03/09/2005CN1592747A Diazabicyclo alkane derivatives with NK1 antagonistic activity
1 ... 4762 4763 4764 4765 4766 4767 4768 4769 4770 4771 4772 4773 4774 4775 4776 4777 4778 4779 4780 4781 4782 ... 7860